home All News open_in_new Full Article

enGene Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

BOSTON & MONTREAL — enGene Holdings Inc. (Nasdaq: ENGN, “enGene” or the “Company”), a clinical-stage, non-viral genetic medicines company, today reported the grant of inducement equity awards to seven newly-hired employees, with a grant date of April 2, 2025. The inducement awards consist of a non-qualified stock options to purchase an aggregate 144,650 of the […]


today 30 h. ago attach_file Other

attach_file Transport
attach_file Events
attach_file Economics
attach_file Politics
attach_file Economics
attach_file Other
attach_file Other
attach_file Culture
attach_file Other
attach_file Events
attach_file Events
attach_file Other
attach_file Events
attach_file Economics
attach_file Economics
attach_file Economics
attach_file Other
attach_file Economics
attach_file Politics
attach_file Economics


ID: 894297061
Add Watch Country

arrow_drop_down